NCT03939455

Mobile Augmented Screening Tool to Increase Adolescent HIV Testing and Linkage to Care

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 295 (actual)
• Sponsor: New York University · Academic / Other
• Sex: All
• Age: 13 Years – 24 Years
• Healthy volunteers: Not accepted

Summary

Because adolescents and young adults face markedly increased HIV risk yet frequently do not test, we propose to complete the Mobile Augmented Screening (MAS) tool designed to increase HIV testing, and to facilitate linkage to care and ongoing prevention education. This tool will help clinicians address undiagnosed youth HIV, and enable young patients to receive much needed treatment and avoid unknowingly transmitting infection. Our product is designed to help existing program staff reach an increased number of clients; and to improve public health by encouraging reluctant young patients to accept important HIV testing and care they may otherwise decline.

Detailed description

Our randomized trial will evaluate HIV test rates among participants who complete a tablet-based intervention, the Mobile Augmented Screening tool (MAS), compared to participants in a treatment as usual (TAU) condition. Research staff will approach 350 emergency department (ED) patients aged 13 - 24 years. Participants will be randomized into the intervention or TAU condition. Participants will be randomized in a 1:1 ratio to the intervention or TAU condition, stratified by patient age (13-17 and 18-24). Within each of these age strata, permuted blocks randomization with varying block sizes will be employed to ensure balance and concealment of allocations prior to randomization. Participants who are randomized into the intervention condition will watch a 5-minute video on a tablet computer, and the tablet will ask intervention participants if they would like an HIV test. Possible responses will be "Yes" or "No". Participants who are randomized into TAU will be offered HIV tests by research staff. All participants in both conditions who agree to HIV testing will be tested by hospital staff in the location where they are receiving treatment. All participants who test will receive their results in person from ED staff before discharge. The primary trial outcome will be percentages of patients, by treatment group, who test for HIV.

Conditions

• HIV Testing

Interventions

Type	Name	Description
OTHER	Mobile Augmented Screening tool	Tablet-based intervention

Timeline

• Start date: 2019-07-22
• Primary completion: 2020-03-05
• Completion: 2020-06-01
• First posted: 2019-05-06
• Last updated: 2021-05-13

Locations

1 site across 1 country: United States